
iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes
VJHemOnc Podcast
00:00
Introduction
The chapter explores the ongoing challenges faced in implementing CAR-T therapy in AML, including identifying suitable target antigens and addressing antigen heterogeneity. The potential of integrating CAR-T cells into an allogenic stem cell approach to reduce relapse after transplantation is also discussed, along with the importance of targeting leukemia stem cells to prevent relapse.
Transcript
Play full episode